Caribou Biosciences, Inc. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/58fe01ae-4cf2-4fb7-810f-b802fd2a49f0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-148.1M | 2025-01-01 – 2025-12-31 | evidence 0001619856-26-000008 |
| FY 2024 | $-149.1M | 2024-01-01 – 2024-12-31 | evidence 0001619856-25-000015 |
| FY 2023 | $-102.1M | 2023-01-01 – 2023-12-31 | evidence 0001619856-24-000013 |
| FY 2022 | $-99.4M | 2022-01-01 – 2022-12-31 | evidence 0001619856-23-000037 |
| FY 2021 | $-66.9M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004233 |
| FY 2020 | $-34.3M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-004233 |
| FY 2019 | $-23.4M | 2019-01-01 – 2019-12-31 | evidence 0000950170-22-004233 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Caribou Biosciences, Inc. — all facts · Revenue · Operating Income